Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Supernus sues over Oxtellar XR patents
Supernus Pharmaceuticals filed suit against Riconpharma and Ingenus, alleging patent infringement connected to their joint abbreviated new drug application for generic oxcarbazepine extended-release tablets. The infringement allegations are claims made by Supernus.